Global Market Report

Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Professional Research Report 2013-2025, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Feb 01, 2019
  • PAGES：188
  • REPORT CODE：GMM158916
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market is offered. The research provides insights for the global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Segmentations:

    By Players:

    • GlaxoSmithKline

    • Astellas Pharmaceuticals

    • AstraZenenca

    • Actavis

    • Salix Pharmaceuticals Ltd

    • Pfizer


    By Types:

    • Preface

    • Eluxadoline

    • Alosetron

    • Rifaximin

    • Loperamide

    • Diphenoxylate + Atropine

    • Dicyclomine and Hyoscyamine


    By End-User:

    • Hospitals

    • Clinics

    • Others


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Share by Types

      • 1.3.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Preface from 2013 to 2025

      • 1.3.3 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Eluxadoline from 2013 to 2025

      • 1.3.4 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Alosetron from 2013 to 2025

      • 1.3.5 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Rifaximin from 2013 to 2025

      • 1.3.6 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Loperamide from 2013 to 2025

      • 1.3.7 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Diphenoxylate + Atropine from 2013 to 2025

      • 1.3.8 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Dicyclomine and Hyoscyamine from 2013 to 2025

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Share by End-Users

      • 1.4.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Hospitals from 2013 to 2025

      • 1.4.3 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Clinics from 2013 to 2025

      • 1.4.4 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Others from 2013 to 2025

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.1 United States Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.2 Canada Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.3 Mexico Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.2 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.1 Germany Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.2 UK Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.3 France Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.4 Italy Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.5 Nordic Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.6 Spain Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.7 BelgiumIrritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.8 Poland Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.9 Russia Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.10 Turkey Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.3 Asia-Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.1 China Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.2 Japan Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.3 Australia and New Zealand Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.4 India Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.5 ASEAN Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.6 South Korea Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.4 Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.1 GCC Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.2 Brazil Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.3 Nigeria Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.4 South Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.5 Argentina Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Preface

      • 3.4.2 Market Size and Growth Rate of Eluxadoline

      • 3.4.3 Market Size and Growth Rate of Alosetron

      • 3.4.4 Market Size and Growth Rate of Rifaximin

      • 3.4.5 Market Size and Growth Rate of Loperamide

      • 3.4.6 Market Size and Growth Rate of Diphenoxylate + Atropine

      • 3.4.7 Market Size and Growth Rate of Dicyclomine and Hyoscyamine


    4 Segmentation of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs for Hospitals

      • 4.4.2 Market Size and Growth Rate of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs for Clinics

      • 4.4.3 Market Size and Growth Rate of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs for Others


    5 Market Analysis by Major Regions

    • 5.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production Analysis by Major Regions

    • 5.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Analysis by Major Regions

    • 5.3 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Import, Consumption and Export Analysis


    6 Product Commodity of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market in Major Countries

    • 6.1 Top 5 Export Countries in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

    • 6.2 Top 5 Import Countries in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis

    • 7.1 North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major Types

    • 7.2 North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major End-Users

    • 7.3 North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major Countries

      • 7.3.1 United States Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 7.3.2 Canada Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 7.3.3 Mexico Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate


    8 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis

    • 8.1 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major Types

    • 8.2 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major Countries

      • 8.3.1 Germany Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 8.3.2 UK Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 8.3.3 France Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 8.3.4 Italy Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 8.3.6 Spain Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 8.3.7 Belgium Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 8.3.8 Poland Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 8.3.9 Russia Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 8.3.10 Turkey Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate


    9 Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis

    • 9.1 Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major Types

    • 9.2 Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major Countries

      • 9.3.1 China Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 9.3.2 Japan Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 9.3.4 India Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 9.3.6 South Korea Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 10.3.2 Brazil Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 10.3.3 Nigeria Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

      • 10.3.4 South Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate 

      • 10.3.5 Argentina Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 GlaxoSmithKline

      • 11.1.1 GlaxoSmithKline Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Astellas Pharmaceuticals

      • 11.2.1 Astellas Pharmaceuticals Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 AstraZenenca

      • 11.3.1 AstraZenenca Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Actavis

      • 11.4.1 Actavis Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Salix Pharmaceuticals Ltd

      • 11.5.1 Salix Pharmaceuticals Ltd Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Pfizer

      • 11.6.1 Pfizer Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 84 Figures and 147 Tables)

    • Figure Product Picture

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Preface from 2013 to 2025

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Eluxadoline from 2013 to 2025

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Alosetron from 2013 to 2025

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Rifaximin from 2013 to 2025

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Loperamide from 2013 to 2025

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Diphenoxylate + Atropine from 2013 to 2025

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Dicyclomine and Hyoscyamine from 2013 to 2025

    • Figure Market Share by Type in 2013

    • Figure Market Share by Type in 2017

    • Figure Market Share by Type in 2025

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Hospitals from 2013 to 2025

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Clinics from 2013 to 2025

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size and Growth Rate of Others from 2013 to 2025

    • Figure Market Share by End-User in 2013

    • Figure Market Share by End-User in 2017

    • Figure Market Share by End-User in 2025

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure United States Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Canada Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Mexico Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Germany Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure UK Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure France Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Italy Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Spain Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Belgium Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Poland Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Russia Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Turkey Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Asia-Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure China Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Japan Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Australia and New Zealand Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure India Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Korea Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure GCC Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Brazil Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nigeria Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Argentina Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Development Trends and Industry Dynamics of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2017

    • Figure Market Share of TOP 5 Players in 2017

    • Figure Market Share of TOP 6 Players from 2013 to 2018

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs by Different Types from 2013 to 2025

    • Table Consumption Share of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs by Different Types from 2013 to 2025

    • Figure Market Size and Growth Rate of Preface

    • Figure Market Size and Growth Rate of Eluxadoline

    • Figure Market Size and Growth Rate of Alosetron

    • Figure Market Size and Growth Rate of Rifaximin

    • Figure Market Size and Growth Rate of Loperamide

    • Figure Market Size and Growth Rate of Diphenoxylate + Atropine

    • Figure Market Size and Growth Rate of Dicyclomine and Hyoscyamine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs by Different End-Users from 2013 to 2025

    • Table Consumption Share of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs by Different End-Users from 2013 to 2025

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Others

    • Table Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production by Major Regions

    • Table Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production Share by Major Regions

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production Share by Major Regions in 2013

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production Share by Major Regions in 2018

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production Share by Major Regions in 2025

    • Table Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Major Regions

    • Table Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Regions

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Regions in 2013

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Regions in 2018

    • Figure Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Regions in 2025

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Import, Consumption and Export Analysis

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

    • Table Top 5 Export Countries' Export Volume Analysis in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

    • Table Top 5 Import Countries' Import Value Analysis in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

    • Table Top 5 Import Countries' Import Volume Analysis in Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2013 to 2018

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Types from 2013 to 2025

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types from 2013 to 2025

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2013

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2018

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2025

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by End-Users from 2013 to 2025

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users from 2013 to 2025

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2013

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2018

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2025

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Major Countries from 2013 to 2025

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries from 2013 to 2025

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2013

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2018

    • Figure North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2025

    • Figure United States Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Canada Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Mexico Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Types from 2013 to 2025

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types from 2013 to 2025

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2013

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2018

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2025

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by End-Users from 2013 to 2025

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users from 2013 to 2025

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2013

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2018

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2025

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Major Countries from 2013 to 2025

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries from 2013 to 2025

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2013

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2018

    • Figure Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2025

    • Figure Germany Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure UK Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure France Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Italy Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Belgium Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Poland Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Russia Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Turkey Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Types from 2013 to 2025

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types from 2013 to 2025

    • Figure Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2013

    • Figure Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2018

    • Figure Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2025

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by End-Users from 2013 to 2025

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users from 2013 to 2025

    • Figure Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2013

    • Figure Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2018

    • Figure Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2025

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Major Countries from 2013 to 2025

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries from 2013 to 2025

    • Figure Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2013

    • Figure Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2025

    • Figure China Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Japan Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Australia and New ZealandIrritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure India Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure South Korea Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Table Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Types from 2013 to 2025

    • Table Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types from 2013 to 2025

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2013

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Types in 2025

    • Table Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by End-Users from 2013 to 2025

    • Table Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users from 2013 to 2025

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2013

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by End-Users in 2025

    • Table Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Major Countries from 2013 to 2025

    • Table Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries from 2013 to 2025

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2013

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Share by Major Countries in 2025

    • Figure GCC Countries Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Brazil Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Nigeria Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure South Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Argentina Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Volume and Growth Rate from 2013 to 2025

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Astellas Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Astellas Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Astellas Pharmaceuticals

    • Table Product and Service Introduction of Astellas Pharmaceuticals

    • Table Company Profile and Development Status of AstraZenenca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZenenca

    • Figure Sales and Growth Rate Analysis of AstraZenenca

    • Figure Revenue and Market Share Analysis of AstraZenenca

    • Table Product and Service Introduction of AstraZenenca

    • Table Company Profile and Development Status of Actavis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis

    • Figure Sales and Growth Rate Analysis of Actavis

    • Figure Revenue and Market Share Analysis of Actavis

    • Table Product and Service Introduction of Actavis

    • Table Company Profile and Development Status of Salix Pharmaceuticals Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals Ltd

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals Ltd

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals Ltd

    • Table Product and Service Introduction of Salix Pharmaceuticals Ltd

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US